G47.13
Recurrent hypersomnia
Clinical Classification Guidelines
Inclusion Terms
- Kleine-Levin syndrome
- Menstrual related hypersomnia
Medical Intelligence & Overview
Recurrent hypersomnia, classified under ICD-10 code G47.13, is a rare neurological sleep disorder characterized by recurrent episodes of excessive daytime sleepiness and prolonged nighttime sleep. This condition can significantly impact daily functioning and overall quality of life. It is often associated with syndromes like Kleine-Levin syndrome and may be linked to menstrual cycles in some cases. Awareness and understanding of this disorder are crucial for accurate diagnosis and management.
Causes & Symptoms
Clinical Causes: Underlying neurological or genetic factors affecting sleep regulation Autoimmune responses targeting brain regions that control sleep Hormonal fluctuations, particularly in menstrual-related hypersomnia Environmental triggers such as stress or infections Possible association with other sleep disorders, like narcolepsy
Key Symptoms: Recurrent episodes of excessive sleepiness lasting days to weeks Prolonged nighttime sleep, sometimes up to 20 hours Occasional confusion, disorientation, or abnormal behavior during episodes Altered energy levels and decreased motivation In some cases, hyperphagia (increased appetite) and altered perceptions Menstrual-related hypersomnia presenting with cyclical episodes aligned with menstrual cycles
Diagnostic & Treatment
Diagnosis Path: Diagnosing recurrent hypersomnia involves a comprehensive clinical assessment, including detailed sleep history and observation of episode patterns. Polysomnography (sleep study) may be used to rule out other sleep disorders. Additional investigations, such as blood tests and brain imaging, help exclude underlying neurological conditions. Criteria outlined in psychiatric and neurological guidelines support the diagnosis, emphasizing the episodic nature and associated features like menstrual links in certain cases.
Treatment Protocols: Management focuses on alleviating symptoms and improving quality of life. Strategies may include scheduled naps, sleep regulation, and pharmacotherapy in some cases. Medications such as stimulants can be considered to reduce sleepiness during wakeful periods. Addressing hormonal fluctuations in menstrual-related hypersomnia might involve hormonal therapy. Supportive care includes psychological counseling and lifestyle adjustments to cope with the episodic nature of the disorder.
Clinical Advice & FAQs
Billing Guidance
Is G47.13 a billable ICD-10 code?
Yes, G47.13 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report G47.13?
Clinical documentation must specify the nature of Recurrent hypersomnia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference